Erratum: CD4 changes among virologically suppressed patients on antiretroviral therapy: A systematic review and meta-analysis (Journal of the International AIDS Society (2015) 18 (20061) DOI:10.7448/IAS.18.1.20061);CD4 changes among virologically suppressed patients on antiretroviral therapy: A systematic review and meta-analysis

Journal of the International AIDS Society

Volumn 18, Issue 1, 2015, Pages

  Ford, Nathan ^a,b   Stinson, Kathryn ^b   Gale, Howard ^c   Mills, Edward J ^d   Stevens, Wendy ^e   González, Mercedes P ^a   Markby, Jessica ^a   Hill, Andrew ^f  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Global Evaluative Sciences   (Canada)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antiretroviral therapy; CD4; HIV; Treatment monitoring; Viral load

Indexed keywords

ANTIVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; ECONOMIC DEVELOPMENT; FOLLOW UP; HUMAN; IMMUNOCOMPROMISED PATIENT; META ANALYSIS; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; STUDY DESIGN; SYSTEMATIC REVIEW; VIRUS LOAD; HIV INFECTIONS; IMMUNOLOGY; MALE; VIROLOGY;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; MALE; VIRAL LOAD;

EID: 84938837728     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.18.1.20653     Document Type: Erratum

References (20)

1. Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T, et al. The future role of CD4 cell count for monitoring antiretroviral therapy. Lancet Infect Dis. 2015;15(2):2417.
2. Anonyms. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health Approach. Geneva: World Health Organization; 2013.
3. Ford N, Stinson K, Davies MA, Cox V, Patten G, Cragg C, et al. Is it safe to drop CD4+ monitoring among virologically suppressed patients: a cohort evaluation from Khayelitsha, South Africa. AIDS. 2014;28(14):20035.
4. Gale HB, Gitterman SR, Hoffman HJ, Gordin FM, Benator DA, Labriola AM, et al. Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts (300 cells/muL and HIV-1 suppression? Clin Infect Dis. 2013;56(9): 13403.
5. Reynolds SJ, Sempa JB, Kiragga AN, Newell K, Nakigozi G, Galiwango R, et al. Is CD4 monitoring needed among Ugandan clients achieving a virologic and immunologic response to treatment? AIDS Patient Care STDS. 2014;28(11): 5758.
6. Hyle EP, Sax PE, Walensky RP. Potential savings by reduced CD4 monitoring in stable patients with HIV receiving antiretroviral therapy. JAMA Intern Med. 2013;173(18):17468.
7. Hamers RL, Sawyer AW, Tuohy M, Stevens WS, Rinke de Wit TF, Hill AM, et al. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis. AIDS. 2012;26(13): 166372.
8. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
9. Fleiss JL. The statistical basis of meta-analysis. Stat Meth Med Res. 1993; 2(2):12145.
10. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Inst Stat Math. 1950;21:60711.
11. Miller J. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat. 1978;32(4):138.
12. Chow E, Read T, Chen M, Fehler G, Bradshaw C, Fairley C. Routine CD4 cell count monitoring seldom contributes to clinical decision-making on antiretroviral therapy in virologically suppressed HIV-infected patients. HIV Med. 2015;16(3):196200.
13. Davies M-A, Ford N, Rabie H, Fatti G, Stinson K, Giddy J, et al. Is it safe to reduce CD4 monitoring in children on antiretroviral therapy with virologic suppression? Pediatr Infect Dis J. 2015. [In Press]
14. Girard PM, Nelson M, Mohammed P, Hill A, van Delft Y, Moecklinghoff C. Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment? AIDS. 2013;27(17):275963.
15. Kizito W, Ngoy B, Ritter H, Etienne W, Kranzer K, Bygrave H. Is CD4 monitoring needed where there is routine viral load? A cohort analysis from Kibera, Kenya. MSF UK Scientific Day, May 2014 [Internet]. [cited 2014 Dec 31]. Available from: http://f1000.com/posters/browse/summary/1095610
16. Phillips AN, Youle M, Lampe F, Sabin CA, Hill A, Ransom D, et al. CD4 cell count changes in individuals with counts above 500 cells/mm and viral loads below 50 copies/ml on antiretroviral therapy. AIDS. 2002;16(7):10735.
17. Stephan C, Hill A, Xi N, van Delft Y, Moecklinghoff C. Research letter: is monitoring for CD4 counts still needed for the management of patients with long-term HIV RNA suppression? J Acquir Immune Defic Syndr. 2012;61(5): e735.
18. Whitlock GG, Ahmed N, Benn P, Edwards S, Waters L. Stop routine CD4 monitoring in HIV-infected patients with fully suppressed virus and CD4 ≥350 cells/ml. Clin Infect Dis. 2013;57(2):3278.
19. Duncan C, Schmid M, Schwab U, Price D, Ong E. Futility of CD4+ monitoring in HIV-1 patients with CD4+ cell count above 350 cells/ml on suppressive antiretroviral therapy. AIDS. 2014;28(17):26389.
20. Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, et al. Effects of CD4 monitoring frequency on clinical endpoints in clinically stable HIV-infected patients with viral suppression. J Acquir Immune Defic Syndr. 2015;69(3):e8592.